| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/06/2008 | US7368623 Two step process; bis-hydrodimerization of butadiene to 1,7-octadiene in presence of palladium catalyst containing one or more tri-substituted monodentate phosphines; catalytic hydrogenation with titanium compound and metal alkyl activator |
| 05/06/2008 | US7368622 Two step process; bis-hydrodimerization of butadiene to 1,7-octadiene in presence of palladium catalyst containing one or more tri-substituted monodentate phosphines; catalytic hydrogenation using non-supported ruthenium complex in aprotic polar solvent of cyclic urea |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration |
| 05/06/2008 | US7368130 Microparticles |
| 05/06/2008 | US7368129 Drug delivery, nutrition, bio-diagnostics, cosmetics, blood products |
| 05/06/2008 | US7368127 Contacting at least one surface of a biomedical device formed from a reactive mixture comprising at least one latent reactive component with a coating effective amount of at least one peptide containing coating |
| 05/06/2008 | US7368126 Controlled release depot formulations |
| 05/06/2008 | US7368125 Amphiphilic polymers for medical applications |
| 05/06/2008 | US7368120 Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| 05/06/2008 | US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 05/06/2008 | US7368102 Pulmonary delivery of aminoglycosides |
| 05/06/2008 | US7367968 Implantable pump with adjustable flow rate |
| 05/06/2008 | CA2609766A1 Product for the management of inflammations, pressure sores and/or oral sores (aphthas) as well as the use of such product |
| 05/06/2008 | CA2468679C Antibiotic formulation and a method of making this formulation |
| 05/06/2008 | CA2463619C Stabilized azithromycin compositions |
| 05/06/2008 | CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 05/06/2008 | CA2400133C Anaesthetic composition |
| 05/06/2008 | CA2378987C A binder for pharmaceutical compositions |
| 05/06/2008 | CA2376780C Intraocular tension lowering compositions for topical administration |
| 05/06/2008 | CA2345675C Two chamber cartridge for atomizers |
| 05/06/2008 | CA2320993C Drug delivery system |
| 05/06/2008 | CA2311311C Biodegradable intra vaginal devices |
| 05/06/2008 | CA2310230C The use of brinzolamide to prevent visual field loss |
| 05/06/2008 | CA2279795C Methods of making an emulsified composition |
| 05/02/2008 | WO2008052184A1 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein |
| 05/02/2008 | WO2008052037A2 Packaging materials for formulations containing 2-pyrrolidone derivatives |
| 05/02/2008 | WO2008052033A2 Ibuprofen composition |
| 05/02/2008 | WO2008051889A1 Rapid release mini-tablets provide analgesia in laboratory animals |
| 05/02/2008 | WO2008051864A2 Method of treating spinal internal disk derangement |
| 05/02/2008 | WO2008051818A2 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 05/02/2008 | WO2008051617A2 Dry granulated pharmaceutical compositions and methods for producing same |
| 05/02/2008 | WO2008051363A2 Stable polypeptide formulations |
| 05/02/2008 | WO2008051283A2 A dried biotherapeutic composition, uses, and device |
| 05/02/2008 | WO2008051245A2 Nanoparticles for use in immunogenic compositions |
| 05/02/2008 | WO2008051101A1 Oral submicron particle delivery system for proteins and process for its production |
| 05/02/2008 | WO2008050987A1 Combination formulation with controlled release comprising metformin and glimepiride |
| 05/02/2008 | WO2008050896A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 05/02/2008 | WO2008050871A1 Crystalline carbapenem compounds |
| 05/02/2008 | WO2008050848A1 Adhesive preparation |
| 05/02/2008 | WO2008050847A1 Granular preparation prevented from caking |
| 05/02/2008 | WO2008050837A1 Drug solution having reduced dissolved oxygen content, method of producing the same and drug solution containing unit having reduced dissolved oxygen content |
| 05/02/2008 | WO2008050807A1 Method for production of liposome preparation |
| 05/02/2008 | WO2008050776A1 Ophthalmic aqeous liquid preparation |
| 05/02/2008 | WO2008050673A1 Adhesive skin patch |
| 05/02/2008 | WO2008050491A1 Film preparation for forming film on skin |
| 05/02/2008 | WO2008050209A1 Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| 05/02/2008 | WO2008050188A2 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof |
| 05/02/2008 | WO2008049903A2 Wide-area parasystemic treatment of skin related conditions |
| 05/02/2008 | WO2008049897A1 Intranasal delivery of polypeptides and proteins |
| 05/02/2008 | WO2008049842A2 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders |
| 05/02/2008 | WO2008049657A2 Use of (meth)acrylate copolymers in slow-release pharmaceutical forms for reducing the influence of ethanol on active ingredient release |
| 05/02/2008 | WO2008049633A2 Spray-freeze-drying process for the preparation of pellets comprising percolation drying |
| 05/02/2008 | WO2008049631A1 Sustained release formulations comprising very low molecular weight polymers |
| 05/02/2008 | WO2008049620A1 Semi-solid controlled release composition |
| 05/02/2008 | WO2008049588A1 Lipid growth factor formulations |
| 05/02/2008 | WO2008049552A1 Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability |
| 05/02/2008 | WO2008049516A2 Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement |
| 05/02/2008 | WO2008049402A2 Nail varnish remover for cosmetic and medical applications |
| 05/02/2008 | WO2008049401A2 Nail varnish for cosmetic and medical applications |
| 05/02/2008 | WO2008049178A1 Stable and ready-to-use oil-in-water propofol microemulsion |
| 05/02/2008 | WO2008032327A3 Organic nanoparticles obtained from microemulsions by solvent evaporation |
| 05/02/2008 | WO2008030557A3 Compositions and methods for enhancing transport through mucus |
| 05/02/2008 | WO2008028885A3 Composition comprising an angiotensin ii receptor antagonist |
| 05/02/2008 | WO2008026765A3 Lyophilized preparation |
| 05/02/2008 | WO2008025425B1 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same |
| 05/02/2008 | WO2008002485A3 Increased amorphous stability of poorly water soluble drugs by nanosizing |
| 05/02/2008 | WO2007136664A3 Antibiotic formulation and method of treatment |
| 05/02/2008 | WO2007130462A3 Treating micrometastases using immunoliposomes comprising a chemotherapeutic agent, a targeting ligand and a hydrophilic polymer |
| 05/02/2008 | WO2007130438A3 Solid dosage formulations |
| 05/02/2008 | WO2007128923A3 Method for the preparation of a biocompatible gel with controlled release of one or more active ingredients with low solubility in water, gels thus obtained and their use |
| 05/02/2008 | WO2007128495A3 Solid pharmaceutical composition of gabapentin |
| 05/02/2008 | WO2007126764A3 Chemically modified viral capsids as targeted delivery vectors for diagnostic and therapeutic agents |
| 05/02/2008 | WO2007124017A3 Easy-to-peel securely attaching bandage |
| 05/02/2008 | WO2007095342A9 Stable corticosteroid mixtures |
| 05/02/2008 | WO2007061796A3 Pharmaceutical composition comprising high-potency sweetener |
| 05/02/2008 | WO2007042281B1 Processing of chitosan and chitosan derivatives |
| 05/02/2008 | CA2667925A1 Dry granulated pharmaceutical compositions and methods for producing same |
| 05/02/2008 | CA2667836A1 Percolative drying for the preparation of particles |
| 05/02/2008 | CA2667466A1 Intranasal delivery of polypeptides and proteins |
| 05/02/2008 | CA2667424A1 Sustained release formulations comprising very low molecular weight polymers |
| 05/02/2008 | CA2667343A1 Drug solution with reduced dissolved oxygen content, production method therefor, and drug solution containing pack with reduced dissolved oxygen content |
| 05/02/2008 | CA2667207A1 Ibuprofen composition |
| 05/02/2008 | CA2667167A1 Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| 05/02/2008 | CA2666953A1 Spontaneous forming ellipsoidal phospholipid unilamellar vesicles |
| 05/02/2008 | CA2666512A1 Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability |
| 05/02/2008 | CA2665024A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 05/02/2008 | CA2648243A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/02/2008 | CA2646511A1 A dried biotherapeutic composition, uses, and device |
| 05/02/2008 | CA2645823A1 Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement |
| 05/02/2008 | CA2631714A1 Nanoparticles for use in immunogenic compositions |
| 05/01/2008 | US20080103490 Devices, systems and methods for medicament delivery |
| 05/01/2008 | US20080103457 Method and System for Treating Heart Failure |
| 05/01/2008 | US20080103120 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/01/2008 | US20080103108 Targeted artificial gene delivery |
| 05/01/2008 | US20080102524 Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity |
| 05/01/2008 | US20080102508 Formulation of adenovirus for gene therapy |
| 05/01/2008 | US20080102275 spraying drugs, cosmetics, nutraceuticals, foods, agriculture or veterinary medicines, with protective coatings comprising polysaccharides, acrylic polymers, lipids, phospholipids or mixtures, to form microstructure particles having controlled release and increased bioavailability |
| 05/01/2008 | US20080102134 comprising Fluvastatin Sodium, hydroxypropyl methylcellulose polymer and hydroxypropyl cellulose, wherein the granules are independent of particle size; capable of being stored at normal atmospheric conditions |